HSBC AKT.ANL. 09/24 RNL/ DE000HS1QLA1 /
21/06/2024 21:40:14 | Var.-0.110 | Denaro21:59:48 | Lettera21:59:48 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
102.560EUR | -0.11% | 102.410 Quantità in denaro: 50,000 |
102.710 Quantità in lettera: 50,000 |
RENAULT INH. EO... | 35.00 EUR | 27/09/2024 | Call |
GlobeNewswire
16:17
TUESDAY DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Akero Therapeutics, Inc. Investors...
GlobeNewswire
16:11
ROSEN, A TOP RANKED LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
16:00
SPR® Therapeutics Recognized as a Top Workplace in Northeast Ohio for the Third Year in a Row
GlobeNewswire
15:50
ENPH INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Enphase Energy, Inc. Investors ...
GlobeNewswire
15:48
PATH INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that UiPath, Inc. Investors with ...
GlobeNewswire
15:45
Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action...
GlobeNewswire
15:00
ROSEN, A LEADING LAW FIRM, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Import...